Recent Advances in Medicinal Chemistry to Treat Tuberculosis – Part-I

Author(s): Santosh K. Srivastava.

Journal Name: Current Topics in Medicinal Chemistry

Volume 19 , Issue 8 , 2019

Become EABM
Become Reviewer

[1]
de Souza, M.V.N.; Nogueira, T.C.M. 4H-1,3-Benzothiazin-4-one a promising class against MDR/XDR-TB. Curr. Top. Med. Chem., 2019, 19(8), 567-578.
[2]
Das, S.; Garg, T.; Srinivas, N.; Dasgupta, A.; Chopra, S. Targeting DNA gyrase to combat Mycobacterium tuberculosis: An update. Curr. Top. Med. Chem., 2019, 19(8), 579-593.
[3]
Kalani, K.; Chaturvedi, V.; Tondon, S.; Srivastava, S.K. Dihydroartemisinin and its analogs: A new class of antitubercular agents. Curr. Top. Med. Chem., 2019, 19(8), 594-599.
[4]
Tiwari, A.; Kumar, A.; Srivastava, G.; Sharma, A. Screening of anti-mycobacterial phytochemical compounds for potential inhibitors against Mycobacterium Tuberculosis isocitrate lyase. Curr. Top. Med. Chem., 2019, 19(8), 600-608.
[5]
Duca, G.; Pogrebnoi, S.; Boldescu, V.; Aksakal, F.; Uncu, A.; Valica, V.; Uncu, L.; Negres, S.; Macaev, F. Tryptanthrin analogues as inhibitors of enoyl-acyl carrier protein reductase: Activity against Mycobacterium tuberculosis, toxicity, modeling of enzyme binding. Curr. Top. Med. Chem., 2019, 19(8), 609-619.
[6]
Zampieri, D.; Cateni, F.; Moneghini, M.; Zacchigna, M.; Laurini, E.; Marson, D.; De Logu, A.; Sanna, A.; Mamolo, M.G. Imidazole and 1,2,4-Triazole-based derivatives gifted with antitubercular activity: Cytotoxicity and computational assessment. Curr. Top. Med. Chem., 2019, 19(8), 620-632.
[7]
Kalani, K.; Alam, S.; Chaturvedi, V.; Khan, F.; Srivastava, S.K. In Vitro, in silico and ex vivo studies of dihydroartemisinin derivatives as antitubercular agents. Curr. Top. Med. Chem., 2019, 19(8), 633-644.


Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 19
ISSUE: 8
Year: 2019
Page: [565 - 566]
Pages: 2
DOI: 10.2174/156802661908190603073535

Article Metrics

PDF: 30
HTML: 3
PRC: 1